Bowen M A, Aruffo A A, Bajorath J
Bristol-Myers Squibb Pharmaceutical Research Institute, Immunology, Inflammation, and Pulmonary Drug Discovery, Princeton, New Jersey, USA.
Proteins. 2000 Aug 15;40(3):420-8.
CD6 is a cell surface receptor belonging to the scavenger receptor cysteine-rich (SRCR) protein superfamily (SRCRSF). It specifically binds activated leukocyte cell adhesion molecule (ALCAM, CD166), a member of the immunoglobulin (Ig) superfamily (IgSF). CD166 was among the first molecules identified as a ligand for an SRCRSF receptor, and the CD6-CD166 interaction was the first interaction characterized involving SRCRSF and IgSF proteins. We focus here on what has been learned about the specifics of the CD6-CD166 interaction from in vitro analysis. The studies are thought to provide an instructive example for the analysis of interactions between single-path transmembrane cell surface proteins. Using soluble recombinant forms, the extracellular binding domains of receptor and ligand have been identified and characterized in a variety of assay systems. Both CD6 and CD166 have been subjected to intense mutagenesis and monoclonal antibody (mAb) binding studies and residues critical for their interaction have been identified. The availability of structural prototypes of both superfamilies has made it possible to map the binding site in CD166 and, more recently, in CD6 and compare these regions to epitopes of mAbs that block, or do not block, the interaction. In addition, the molecular basis of observed cross-species receptor-ligand interactions could be rationalized. These studies illustrate the value of structural templates for the interpretation of sequence and mutagenesis analyses. Proteins 2000;40:420-428.
CD6是一种细胞表面受体,属于富含半胱氨酸的清道夫受体(SRCR)蛋白超家族(SRCRSF)。它特异性结合活化白细胞细胞黏附分子(ALCAM,CD166),后者是免疫球蛋白(Ig)超家族(IgSF)的成员。CD166是最早被鉴定为SRCRSF受体配体的分子之一,而CD6-CD166相互作用是首次被表征的涉及SRCRSF和IgSF蛋白的相互作用。我们在此聚焦于从体外分析中所了解到的CD6-CD166相互作用的具体细节。这些研究被认为为分析单通道跨膜细胞表面蛋白之间的相互作用提供了一个有启发性的例子。利用可溶性重组形式,受体和配体的细胞外结合结构域已在多种检测系统中被鉴定和表征。CD6和CD166都已接受了深入的诱变和单克隆抗体(mAb)结合研究,并确定了对它们相互作用至关重要的残基。两个超家族结构原型的可得性使得绘制CD166以及最近CD6中的结合位点成为可能,并将这些区域与阻断或不阻断相互作用的mAb的表位进行比较。此外,观察到的跨物种受体-配体相互作用的分子基础也可以得到合理的解释。这些研究说明了结构模板在解释序列和诱变分析方面的价值。《蛋白质2000》;40:420 - 428。